VIC Team

VIC Team

Recent Posts

Opportunity Assessment: How To Vet So Much Tech

How do you successfully evaluate hundreds of complicated technologies each year, with a team spread across the country and resources that span the globe? This was the challenge that VIC needed to solve back in early...

Partner Spotlight: SeedSprint

SeedSprint is the innovation ecosystem that connects emerging technologies with industry partners. The platform is free for emerging technology companies and research institutions and available to industry at a flat...

Neurexis Therapeutics Awarded Colorado Advanced Industries Accelerator Grant

AURORA, CO - Neurexis Therapeutics, Inc. announced today that it has been approved for funding as part of the Colorado Office of Economic Development and International Trade’s (OEDIT) Advanced Industries Accelerator...

Zebra Analytix Awarded NIH Funding to Improve Workplace Safety

FAYETTEVILLE, AR - Zebra Analytix—a VIC Technology Venture Development portfolio company—announced today that it has received a Small Business Innovation Research (SBIR) grant from the National Institute of...

VIC Fellow Spotlight: Dr. Natalie Gassman

The VIC Fellows Program was created in late 2019 as a mechanism for individuals with specific expertise to learn about and be involved in identifying and evaluating promising life science innovations from universities,...

CardioWise Makes FDA Submission With Request for Expedited Approval for COVID-19

This month, CardioWise filed a 510(k) Application for its machine learning-based heart health analysis software known as SQuEEZTM. The software, combined with cardiac computerized tomography (CT) imaging, has the...

VIC Portfolio Companies and Pipeline Technologies with Pandemic Impact

Our current daily activities bear little resemblance to the routines as of as recently as a month ago. COVID-19 has had an obvious and significant impact on the American people. For those suffering from chronic...

VIC Technology Venture Development Forms New Portfolio Company: Neurexis Therapeutics

Neurexis Therapeutics, Inc. to develop a new medication for the prevention of brain damage following ischemic events such as stroke

VIC Launches New Fellows Program

The VIC Fellows Program was created as a mechanism through which individuals with specific expertise can learn about and be involved in the process of identifying and evaluating promising life science innovation from...

VIC Technology Venture Development Forms New Portfolio Company: Filtravate

Company co-founded with Reza Foudazi, PhD, developer of a platform membrane technology with broad applications in bioprocessing and industrial filtration.

FEATURED RESOURCES

Updates
VIC Tech Announces New Class of Fellows
Insight
Our Life Science and Healthcare Future
White Paper
Portfolio Diversification in Times of Market Volatility
Interview
Inside the Office of Technology Commercialization at the University of Kentucky with Holly Clark, PhD, Senior Commercialization Manager
Insight
Seven Reasons Venture Capital-Stage Companies Should Become Part of Your Investment Portfolio
White Paper
Investing in Medical Devices & Diagnostics – Industry Trends and Investor Activity
News
Nob Hill Therapeutics Secures Series A Funding to Advance Breakthrough Respiratory Technologies
Interview
VIC Fellows Spotlight: Matthew Leming, PhD
From The Corner Office
From the Corner Office: Zebra Analytix